Anxiety DisordersDavid J. Nutt, James C. Ballenger John Wiley & Sons, 15 เม.ย. 2008 - 560 หน้า Rapid developments in recent years in basic science and pharmacology has greatly increased understanding of the causes of anxiety disorders. This has led to a large number of new drug treatments from the pharmaceutical industry. This book makes sense of these advances and presents a coherent account of diagnosis and management from the clinical point of view. Chapters are in the form of surveys and digests of the recent literature and are interspersed with clinical guidelines, diagnostic and therapeutic points and are well illustrated. |
ฉบับอื่นๆ - ดูทั้งหมด
คำและวลีที่พบบ่อย
abnormalities activity adolescents agonists agoraphobia alprazolam American Psychiatric Association AmJ Psychiatry antidepressants anxiolytic Arch Gen Psychiatry assessment behavioral inhibition benzodiazepine Biol Psychiatry brain buspirone Charney chronic Clin Psychiatry Clin Psychopharmacol clinical clomipramine cognitive comorbid compared compulsive controls cortex criteria decrease diagnostic diazepam dose double-blind drug DSM-IV effects efficacy exposure factors fear fluoxetine fluvoxamine function gene genetic hydroxyzine imipramine improvement increased Klein lactate Liebowitz major depression ment metabolism mg/day nefazodone Nutt obsessive obsessive-compulsive disorder onset panic attacks panic disorder panic patients panicogenic paroxetine patients with panic patients with PD patients with social PD patients pharmacological placebo placebo-controlled post-traumatic stress disorder prevalence Psychiatry Psychiatry Res Psychol PTSD rates reduced reported respiratory response sample schizophrenia serotonergic serotonin side-effects significant significantly sleep social anxiety disorder social phobia somatic specific SSRIs Stein suggested Suppl syndrome therapy tion trauma treatment trial venlafaxine